In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers said. The study, co-authored by Yale assistant professor of medicine Brinda Emu, M.D., was published in the New England Journal of Medicine.
Published: Sunday, September 2, 2018
